ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

EJMCR. 2024; 8(5): 93-98


Encapsulating Peritoneal Sclerosis in a hemodialysis patient: a case report

Nurul Huda Abdullah, Fattah Rahiman Ghazali, Najihah Hussin, Muhammad Imran Kamarudin.



Abstract
Download PDF Post

Background: Encapsulating peritoneal sclerosis is a rare manifestation nowadays.

Case report: This was a case report of a young female with ESKD on hemodialysis for more than 6 months with a previous history of continuous ambulatory peritoneal dialysis (CAPD) and recurrent peritonitis which currently presented with painful abdominal distension. The CT scan of the abdomen showed a clumping of small bowel loops at the left side encased into a thin fibrocartilaginous membrane. Initially, she was treated for intrabdominal sepsis however after recurrent admission, IV Methylprednisolone was started followed by high dose steroids and tamoxifen as a treatment for EPS. Surprisingly she improved and had a good clinical response. She had readmitted again after a few months with abdominal pain due to an abrupt stop in steroid but improved again after the steroid was started.

Conclusion: Abdominal pain in a patient with history of CAPD peritonitis needs to raise suspicion of EPS even though is rare Radiological Imaging is helpful in making early diagnosis. The most important thing is steroid as a mainstay of the treatment of EPS besides tamoxifen with a minimal one-year duration or lifelong as surgical intervention is very risky.

Key words: encapsulating peritoneal sclerosis, peritonitis, clumping of bowel loops, tamoxifen, steroid.







Bibliomed Article Statistics

34
34
39
10
15
13
16
19
14
17
26
9
R
E
A
D
S

16

9

12

10

14

17

13

10

18

11

17

5
D
O
W
N
L
O
A
D
S
040506070809101112010203
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.